TR200100779T2 - Yeni bir bileşim. - Google Patents
Yeni bir bileşim.Info
- Publication number
- TR200100779T2 TR200100779T2 TR2001/00779T TR200100779T TR200100779T2 TR 200100779 T2 TR200100779 T2 TR 200100779T2 TR 2001/00779 T TR2001/00779 T TR 2001/00779T TR 200100779 T TR200100779 T TR 200100779T TR 200100779 T2 TR200100779 T2 TR 200100779T2
- Authority
- TR
- Turkey
- Prior art keywords
- composition
- component
- new combination
- discomfort
- dicyclobutylamino
- Prior art date
Links
- 239000000203 mixture Substances 0.000 abstract 4
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000006558 Dental Calculus Diseases 0.000 abstract 1
- -1 N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen Chemical class 0.000 abstract 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000002996 emotional effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000012458 free base Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- 229960002296 paroxetine Drugs 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Bir ilk bilesen (a) olarak (R)-3-N, N-disiklobutilamino-8-floro-3, 4-dihidro-2H-1-benzopiran-5-karboksamid hidrojen (2R,3R)-tartar monohidrat ve bir ikinci bilesen (b) olarak serbest baz, ya da bundan dolayi eczacilikla ilgili kabul edilebilir bir tuz ve/veya eriyik formunda olan paroksetin içeren bir bilesim ile ilgilidir, bundan dolayi bahsedilen bilesimi içeren eczacilikla ilgili formüller, kullanimi ve bahsedilen bilesimi içeren teçhizat gibi, ruhsal rahatsizliklar ve endiseyle ilgili rahatsizliklar gibi duygusal rahatsizliklarin tedavisinde bir yöntemdir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803156A SE9803156D0 (sv) | 1998-09-16 | 1998-09-16 | A new composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200100779T2 true TR200100779T2 (tr) | 2001-10-22 |
Family
ID=20412627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/00779T TR200100779T2 (tr) | 1998-09-16 | 1999-09-13 | Yeni bir bileşim. |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1128825A1 (tr) |
| JP (1) | JP2002524508A (tr) |
| KR (1) | KR20010099647A (tr) |
| CN (1) | CN1317964A (tr) |
| AR (1) | AR021808A1 (tr) |
| AU (1) | AU6378099A (tr) |
| BR (1) | BR9913748A (tr) |
| CA (1) | CA2342341A1 (tr) |
| CZ (1) | CZ2001961A3 (tr) |
| EE (1) | EE200100157A (tr) |
| HU (1) | HUP0103544A3 (tr) |
| ID (1) | ID28785A (tr) |
| IL (1) | IL141519A0 (tr) |
| IS (1) | IS5879A (tr) |
| NO (1) | NO20011312L (tr) |
| PL (1) | PL346763A1 (tr) |
| SE (1) | SE9803156D0 (tr) |
| SK (1) | SK3262001A3 (tr) |
| TR (1) | TR200100779T2 (tr) |
| WO (1) | WO2000015218A1 (tr) |
| ZA (1) | ZA200101946B (tr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1358177B1 (en) * | 2000-10-13 | 2006-08-02 | NeuroSearch A/S | Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| WO2006093192A1 (ja) * | 2005-03-04 | 2006-09-08 | Tokyo Medical And Dental University | 覚醒剤精神病及び統合失調症の再発防止治療薬 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9501567D0 (sv) * | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
-
1998
- 1998-09-16 SE SE9803156A patent/SE9803156D0/xx unknown
-
1999
- 1999-09-13 AU AU63780/99A patent/AU6378099A/en not_active Abandoned
- 1999-09-13 HU HU0103544A patent/HUP0103544A3/hu unknown
- 1999-09-13 BR BR9913748-8A patent/BR9913748A/pt not_active Application Discontinuation
- 1999-09-13 EP EP99951319A patent/EP1128825A1/en not_active Withdrawn
- 1999-09-13 CZ CZ2001961A patent/CZ2001961A3/cs unknown
- 1999-09-13 SK SK326-2001A patent/SK3262001A3/sk unknown
- 1999-09-13 JP JP2000569802A patent/JP2002524508A/ja active Pending
- 1999-09-13 WO PCT/SE1999/001597 patent/WO2000015218A1/en not_active Ceased
- 1999-09-13 IL IL14151999A patent/IL141519A0/xx unknown
- 1999-09-13 KR KR1020017003337A patent/KR20010099647A/ko not_active Withdrawn
- 1999-09-13 CN CN99811010A patent/CN1317964A/zh active Pending
- 1999-09-13 ID IDW20010581A patent/ID28785A/id unknown
- 1999-09-13 EE EEP200100157A patent/EE200100157A/xx unknown
- 1999-09-13 CA CA002342341A patent/CA2342341A1/en not_active Abandoned
- 1999-09-13 TR TR2001/00779T patent/TR200100779T2/tr unknown
- 1999-09-13 PL PL99346763A patent/PL346763A1/xx unknown
- 1999-09-15 AR ARP990104626A patent/AR021808A1/es not_active Application Discontinuation
-
2001
- 2001-03-07 IS IS5879A patent/IS5879A/is unknown
- 2001-03-08 ZA ZA200101946A patent/ZA200101946B/en unknown
- 2001-03-15 NO NO20011312A patent/NO20011312L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK3262001A3 (en) | 2001-08-06 |
| CZ2001961A3 (cs) | 2001-08-15 |
| NO20011312L (no) | 2001-05-16 |
| NO20011312D0 (no) | 2001-03-15 |
| EP1128825A1 (en) | 2001-09-05 |
| EE200100157A (et) | 2002-08-15 |
| IS5879A (is) | 2001-03-07 |
| HUP0103544A3 (en) | 2003-12-29 |
| CA2342341A1 (en) | 2000-03-23 |
| WO2000015218A1 (en) | 2000-03-23 |
| PL346763A1 (en) | 2002-02-25 |
| AU6378099A (en) | 2000-04-03 |
| ZA200101946B (en) | 2002-06-10 |
| AR021808A1 (es) | 2002-08-07 |
| CN1317964A (zh) | 2001-10-17 |
| IL141519A0 (en) | 2002-03-10 |
| SE9803156D0 (sv) | 1998-09-16 |
| JP2002524508A (ja) | 2002-08-06 |
| BR9913748A (pt) | 2001-07-10 |
| KR20010099647A (ko) | 2001-11-09 |
| ID28785A (id) | 2001-07-05 |
| HUP0103544A2 (hu) | 2002-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200102800T2 (tr) | Yeni bileşikler. | |
| TR200101398T2 (tr) | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. | |
| ATE234092T1 (de) | 2-alkylpyrrolidine | |
| SE9504661D0 (sv) | New compounds | |
| PT1204654E (pt) | Benzofurilpiperazinas agonistas do receptor 5-ht2c da serotonina | |
| BR0007781A (pt) | Conjugado fisiologicamente ativo, composição, e, processo para a produção de um conjugado de peg-gcsf | |
| EA200100713A1 (ru) | Препаративная форма галантамина с регулируемым выделением | |
| DE69429524D1 (de) | Aminocyclohexylester und ihre anwendung | |
| YU401A (sh) | Sredstva sa antidepresivnim dejstvom | |
| SE9702773D0 (sv) | Novel compounds | |
| AU2059499A (en) | Use of heterocyclic quaternary polyammonium polymers as protective agent for keratin fibres and cosmetic compositions | |
| BR9813957A (pt) | Uso de antagonistas da vasopressina | |
| YU13301A (sh) | Muskarinski agonisti i antagonisti | |
| TR199900486T2 (tr) | Aziniloksi ve fenoksi-diaril-karbonasit türevleri. | |
| ATE82960T1 (de) | Zusammenstellungen fuer die permanente aenderung der haarstruktur. | |
| BR0012696A (pt) | Composição oftálmica | |
| PE20010956A1 (es) | Derivados de isoquinolina y quinazolina con afinidad por los receptores de serotonina combinados 5-ht1a, 5-ht1b, 5-ht1d | |
| BR9914848A (pt) | Composição e processo para o tratamento de distúrbios da retina externa | |
| ATE213937T1 (de) | Spezielle halofantrinhaltige zusammensetzungen | |
| ES2163658T3 (es) | Nueva composicion reductora y nuevo procedimiento para la deformacion permanente de los cabellos. | |
| BR9915955A (pt) | Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona | |
| AP2001002188A0 (en) | 5HT1 antagonists for antidepressant therapy. | |
| DE60029954D1 (de) | Dermale anästhetika | |
| PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
| BG105539A (bg) | Елетриптан хидробромид монохидрат |